Read + Share
Amedeo Smart
Independent Medical Education
Reardon S. FDA approves Alzheimer's drug lecanemab amid safety concerns. Nature 2023;613:227-228.PMID: 36627422
Email
LinkedIn
Facebook
Twitter
Privacy Policy